Longitudinal Diary Data: Six Months Real-world Implementation of Affordable Companion Robots for Older People in Supported Living

被引:20
|
作者
Bradwell, Hannah L. [1 ]
Winnington, Rhona [2 ]
Thill, Serge [3 ]
Jones, Ray B. [1 ]
机构
[1] Univ Plymouth, Fac Hlth, Plymouth, Devon, England
[2] Auckland Univ Technol, Dept Nursing, Auckland, New Zealand
[3] Radbound Univ, Donders Ctr Cognit, Nijmegen, Netherlands
关键词
Companion robots; older people; wellbeing; DEMENTIA; SYMPTOMS; CARE;
D O I
10.1145/3371382.3378256
中图分类号
TP3 [计算技术、计算机技术];
学科分类号
0812 ;
摘要
Companion robots have potential for improving wellbeing within aged care, however literature focuses on shorter-term studies often using relatively expensive platforms, raising concerns around novelty effects and economic viability. Here, we report ecologically valid diary data from two supported living facilities for older people with dementia or learning difficulties. Both sites implemented Joy for All robot animals and maintained diaries for six months. Entries were analysed using thematic analysis. We found robot use increased over the six months, changing from short, structured sessions to mainly permanent availability. Thus previously reported concerns on novelty were not warranted. Both sites reported positive outcomes including reminiscence, improved communication and potential wellbeing benefits (reduced agitation/anxiety). Incidences of negative response included devices described as 'creepy.' Devices appeared sufficiently robust for prolonged daily use with multiple users. Overall, we provide insight into real-world implementation of affordable companion robots, and longitudinal development of use.
引用
收藏
页码:148 / 150
页数:3
相关论文
共 43 条
  • [41] Two-year outcomes of dolutegravir (DTG) plus lamivudine (3TC) in ART-naive and pre-treated people living with HIV in Germany: real-world data from the German URBAN cohort
    Beer, D.
    Scherzer, J.
    Noe, S.
    Scholten, S.
    Wyen, C.
    Postel, N.
    Degen, O.
    Sabranski, M.
    Westermayer, B.
    Dymek, K.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 112 - 113
  • [42] Patient-reported outcome (PRO) measures at 12 months (12M) in a real-world cohort of people living with HIV (PLWH) with a high prevalence of comorbidities receiving bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in Europe, Canada, and Israel
    Brunetta, J.
    Monforte, A. D'Arminio
    Elbirt, D.
    Postel, N.
    van Welzen, B.
    Zeggagh, J.
    Milinkovic, A.
    Marongiu, A.
    Heinzkill, M.
    Thorpe, D.
    Cornejo, A. Torres
    Antela, A.
    HIV MEDICINE, 2021, 22 : 108 - 110
  • [43] Three-year outcomes for Dolutegravir (DTG) plus Lamivudine (3TC) in ARTnaive and pre-treated people living with HIV-1 (PLHIV) in Germany: Real-world data from the German URBAN cohort
    Noe, S.
    Scholten, S.
    Wyen, C.
    Sabranski, M.
    Postel, N.
    Degen, O.
    Beer, D.
    Ummard-Berger, K.
    Westermayer, B.
    Dymek, K. M.
    Scherzer, J.
    HIV MEDICINE, 2023, 24 : 137 - 139